Treatment for rare metabolic disease approved
FDA approved metreleptin for injection (Myalept, Amylin Pharmaceuticals) as replacement therapy to treat the complications of leptin deficiency, in addition to diet, in patients with congenital...
View ArticleDrugs in Perspective: Myalept (metreleptin)
Lipodystrophy is an orphan disease. Only an estimated few thousand patients have this disease worldwide, although robust epidemiologic data are not available.1,2 Lipodystrophy is a group of chronic,...
View Article
More Pages to Explore .....
